Description

FLUSURE™/RESPISURE ONE^® is a freeze-dried preparation containing 2 type-A field isolates, subtypes H1N1 and H3N2, of inactivated swine influenza viruses grown on an established cell line, plus a liquid preparation of a chemically inactivated whole cell culture of M. hyopneumoniae. The liquid component contains Amphigen^®, a unique oil-in-water adjuvant to enhance the immune response, and is used to rehydrate the freeze-dried vaccine.

Approved Uses

Vaccination of healthy swine 3 weeks of age or older as an aid in preventing respiratory disease caused by swine influenza virus (SIV) subtypes H1N1 and H3N2 and erysipelas caused by Erysipelothrix rhusiopathiae for a period of 20 weeks.

Key Features

• Proven, effective, bivalent swine-flu protection. FLUSURE™ aids in the prevention of respiratory disease caused by swine influenza (SIV) subtypes H1N1 and H3N2– the two subtypes most often diagnosed in U.S. swine herds.
• Safe. In safety studies on hundreds of pigs and pregnant sows, animals vaccinated with FLUSURE showed no systemic reactions. Pigs vaccinated with FLUSURE were 100% injection-site-reaction-free, and sows were 99.5% injection-site-reaction-free. Pregnant sows vaccinated with FLUSURE farrowed at similar rates and had pigs born live, born dead and mummies similar to saline vaccinated control sows.
• Flexible. The freeze-dried formulation provides for greater flexibility when dosing.
• Reduction of lung lesions. Pigs vaccinated with FLUSURE/RESPISURE ONE at 3 weeks of age showed an 82% reduction in lung lesions caused by a virulent mycoplasma challenged. This study confirmed that FLUSURE does not interfere with RESPISURE ONE^®.
• One dose administration. RESPISURE ONE is the first mycoplasma vaccine with a single dose administration and 23 weeks duration of immunity.
• Flexibility of vaccination timing. RESPISURE ONE can be administered to pigs at three weeks of age or older.

Packaging

50-dose vial, 250-dose vial